Community is at the core of BioDAO forming the foundation of all operational and strategic decisions. Members can contribute, complete tasks, and gain new skills relevant to the process of drug discovery and translation.
Decentralization enables creation of more effective sourcing of deals and skills by engaging a global community of experts, operators, and investors towards a common goal.
Valueless governance token will allow members to participate in governance and can be earned for various contributions (e.g., deal flow, due diligence, DAO ops). BioDAO token has not been launched yet.
Too financially uncertain to work for early stage biotech
Science outside of biotech hotspots is ignored
Early stage assets are not funded (the “valley of death”)